SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000318306-07-000014
Filing Date
2007-04-13
Accepted
2007-04-13 15:02:53
Documents
2
Period of Report
2007-04-13
Effectiveness Date
2007-04-13

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT AND NOTICE def14a.htm DEF 14A 561654
2 AUDIT COMMITTEE CHARTER ex-def01.htm EX-99.2A CHARTER 33646
  Complete submission text file 0000318306-07-000014.txt   596955
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-15771 | Film No.: 07765672
SIC: 2834 Pharmaceutical Preparations